Percutaneous Device Closure of Patent Foramen Ovale in Patients With Presumed Cryptogenic Stroke or Transient Ischemic Attack. The Mayo Clinic Experience

JACC: Cardiovascular Interventions

Volumn 2, Issue 5, 2009, Pages 404-411

  Ford, Monique A ^a   Reeder, Guy S ^a   Lennon, Ryan J ^a   Brown, Robert D ^a   Petty, George W ^a   Cabalka, Allison K ^a   Cetta, Frank ^a   Hagler, Donald J ^a  

^a Mayo Clinic   (United States)

Author keywords

cryptogenic stroke; patent foramen ovale; transient ischemic attack

Indexed keywords

ACETYLSALICYLIC ACID; BLOOD CLOTTING FACTOR 5 LEIDEN; CLOPIDOGREL;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HAZARD RATIO; HEART ANEURYSM; HEART RIGHT VENTRICLE PRESSURE; HEART VENTRICLE PRESSURE; HUMAN; KAPLAN MEIER METHOD; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PATENT FORAMEN OVALE; PATIENT SAFETY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROTEIN S DEFICIENCY; RECURRENCE RISK; RECURRENT DISEASE; RISK FACTOR; STROKE; TELEPHONE; THROMBOPHILIA; TRANSIENT ISCHEMIC ATTACK; ECHOGRAPHY; FACTUAL DATABASE; FORAMEN OVALE, PATENT; ISCHEMIC ATTACK, TRANSIENT; MIDDLE AGED; RETROSPECTIVE STUDY; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME; UNITED STATES; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; DATABASES, FACTUAL; FEMALE; FORAMEN OVALE, PATENT; HUMANS; ISCHEMIC ATTACK, TRANSIENT; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK FACTORS; STROKE; TREATMENT OUTCOME; UNITED STATES; ANGIOPLASTY, BALLOON, CORONARY; KAPLAN-MEIER ESTIMATE;

EID: 65549121300     PISSN: 19368798     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcin.2008.12.015     Document Type: Article

References (29)

1. Sacco R.L., Ellenberg J.H., Mohr J.P., et al. Infarcts of undetermined cause: the NINCDS Stroke Data Bank. Ann Neurol 25 (1989) 382-390
2. Petty G.W., Brown Jr. R.D., Whisnant J.P., Sicks J.D., O'Fallon W.M., and Wiebers D.O. Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke 30 (1999) 2513-2516
3. Meissner I., Whisnant J.P., Khandheria B.K., et al. Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc 74 (1999) 862-869
4. Tobis M.J., and Azarbal B. Does patent foramen ovale promote cryptogenic stroke and migraine headache?. Tex Heart Inst J 32 (2005) 362-365
5. Tobis J. The case for closing PFOs. Catheter Cardiovasc Interv 55 (2002) 195-196
6. Lechat P., Mas J.L., Lascault G., et al. Prevalence of patent foramen ovale in patients with stroke. N Engl J Med 318 (1988) 1148-1152
7. Mas J.L., Arquizan C., Lamy C., et al. Recurrent cerebrovascular events associated with patent foramen ovale, atrial septal aneurysm, or both. N Engl J Med 345 (2001) 1740-1746
8. Aggarwal K., Jayam V.K., Meyer M.A., Nayak A.K., and Nathan S. Thrombus-in-transit and paradoxical embolism. J Am Soc Echocardiogr 15 (2002) 1021-1022
9. Fabricius A.M., Kruger M., Hanke M., and Mohr F.W. Caught in the act: impending paradoxical embolism. Asian Cardiovasc Thorac Ann 10 (2002) 342-343
10. Doufekias E., Segal A.Z., and Kizer J.R. Cardiogenic and aortogenic brain embolism. J Am Coll Cardiol 51 (2008) 1049-1059
11. Bogousslavsky J., Garazi S., Jeanrenaud X., Aebischer N., Van Melle G., and Lausanne Stroke with Paradoxal Embolism Study Group. Stroke recurrence in patients with patent foramen ovale: the Lausanne Study. Neurology 46 (1996) 1301-1305
12. Overell J.R., Bone I., and Lees K.R. Interatrial septal abnormalities and stroke: a meta-analysis of case-control studies. Neurology 55 (2000) 1172-1179
13. Handke M., Harloff A., Olschewski M., Hetzel A., and Geibel A. Patent foramen ovale and cryptogenic stroke in older patients. N Engl J Med 357 (2007) 2262-2268
14. Petty G.W., Khandheria B.K., Meissner I., et al. Population-based study of the relationship between patent foramen ovale and cerebrovascular ischemic events. Mayo Clin Proc 81 (2006) 602-608
15. Homma S., Sacco R.L., Di Tullio M.R., Sciacca R.R., and Mohr J.P. Effect of medical treatment in stroke patients with patent foramen ovale: patent foramen ovale in Cryptogenic Stroke Study. Circulation 105 (2002) 2625-2631
16. Opotowsky A.R., Landzberg M.J., Kimmel S.E., and Webb G.D. Trends in the use of percutaneous closure of patent foramen ovale and atrial septal defect in adults, 1998 to 2004. JAMA 299 (2008) 521-522
17. Homma S., and Sacco R.L. Patent foramen ovale and stroke. Circulation 112 (2005) 1063-1072
18. Khairy P., O'Donnell C.P., and Landzberg M.J. Transcatheter closure versus medical therapy of patent foramen ovale and presumed paradoxical thromboemboli: a systematic review. Ann Intern Med 139 (2003) 753-760
19. Windecker S., Wahl A., Chatterjee T., et al. Percutaneous closure of patent foramen ovale in patients with paradoxical embolism: long-term risk of recurrent thromboembolic events. Circulation 101 (2000) 893-898
20. Hanley P.C., Tajik A.J., Hynes J.K., et al. Diagnosis and classification of atrial septal aneurysm by two-dimensional echocardiography: report of 80 consecutive cases. J Am Coll Cardiol 6 (1985) 1370-1382
21. Johnston S.C. Clinical practice. Transient ischemic attack. N Engl J Med 347 (2002) 1687-1692
22. Adams Jr. H.P., Bendixen B.H., Kappelle L.J., et al. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke 24 (1993) 35-41
23. Khositseth A., Cabalka A.K., Sweeney J.P., et al. Transcatheter Amplatzer device closure of atrial septal defect and patent foramen ovale in patients with presumed paradoxical embolism. Mayo Clin Proc 79 (2004) 35-41
24. Wahl A., Kunz M., Moschovitis A., et al. Long-term results after fluoroscopy guided closure of patent foramen ovale for secondary prevention of paradoxical embolism. Heart 94 (2008) 336-341
25. Rosamond W., Flegal K., Friday G., et al., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2007 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 115 (2007) e69-e171
26. Cabanes L., Mas J.L., Cohen A., et al. Atrial septal aneurysm and patent foramen ovale as risk factors for cryptogenic stroke in patients less than 55 years of age. A study using transesophageal echocardiography. Stroke 24 (1993) 1865-1873
27. Nedeltchev K., Arnold M., Wahl A., et al. Outcome of patients with cryptogenic stroke and patent foramen ovale. J Neurol Neurosurg Psychiatry 72 (2002) 347-350
28. Karttunen V., Hiltunen L., Rasi V., Vahtera E., and Hillbom M. Factor V Leiden and prothrombin gene mutation may predispose to paradoxical embolism in subjects with patent foramen ovale. Blood Coagul Fibrinolysis 14 (2003) 261-268
29. Black S., Cucchiara R.F., Nishimura R.A., and Michenfelder J.D. Parameters affecting occurrence of paradoxical air embolism. Anesthesiology 71 (1989) 235-241